← Back to Clinical Trials
Recruiting NCT07160621

NCT07160621 Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07160621
Status Recruiting
Phase
Sponsor St. Jude Children's Research Hospital
Condition Childhood Cancer Survivor
Study Type INTERVENTIONAL
Enrollment 228 participants
Start Date 2025-09-05
Primary Completion 2028-02

Trial Parameters

Condition Childhood Cancer Survivor
Sponsor St. Jude Children's Research Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 228
Sex ALL
Min Age 10 Years
Max Age 17 Years
Start Date 2025-09-05
Completion 2028-02
Interventions
Cognitive Behavioral Therapy (CBT)EducationQuestionnaires

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of the study is to determine if an adapted mobile cognitive behavioral therapy (CBT) app (WebMAP Onc) is more effective than standard pain education in reducing chronic pain and improving daily functioning in adolescent survivors of pediatric cancer. This randomized study led by St. Jude Children's Research Hospital will involve 228 participants (114 adolescent survivors and 114 caregivers) across four U.S. hospitals. Outcomes include pain reduction, improved function, and the role of social determinants of health. Assessments occur at baseline, post-treatment, and 3-month follow-up.

Eligibility Criteria

Inclusion Criteria: * Adolescent Participants * 10-17-year-old survivors of childhood cancer or those who received cancer directed therapies (e.g., Langerhan's Histiocytosis) * At least one-year post treatment completion * Pain present for 3 months or longer * Pain interfering with at least one area of daily functioning * Parent/Caregiver Participants * ≥ 18 years of age * Legally authorized to provide informed consent for the adolescent participant Exclusion Criteria: * Adolescent Participants * Serious comorbid psychiatric condition * Current substance abuse as determined by the Substance Use Screening Questionnaire * History of development delay or significant cognitive impairment * Note: A participant who completed the feasibility study (ADAPTED) cannot participate in the subsequent clinical trial (ADAPTED2) * Parent/Caregiver Participants * Not fluent in English or Spanish * Unable to provide consent for own participation or for the participation of the adolescent participant

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology